table of content
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics Infectious Disease Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics Infectious Disease Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics Infectious Disease Testing Overall Market Size
2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size: 2021 VS 2028
2.2 Global Molecular Diagnostics Infectious Disease Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnostics Infectious Disease Testing Players in Global Market
3.2 Top Global Molecular Diagnostics Infectious Disease Testing Companies Ranked by Revenue
3.3 Global Molecular Diagnostics Infectious Disease Testing Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics Infectious Disease Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Molecular Diagnostics Infectious Disease Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics Infectious Disease Testing Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnostics Infectious Disease Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics Infectious Disease Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Molecular Diagnostics Infectious Disease Testing Market Size Markets, 2021 & 2028
4.1.2 Bacterial Infectious Disease Testing
4.1.3 Viral Infectious Disease Testing
4.1.4 Parasitic Infectious Disease Testing
4.2 By Type - Global Molecular Diagnostics Infectious Disease Testing Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2022
4.2.2 By Type - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2023-2028
4.2.3 By Type - Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics Infectious Disease Testing Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Laboratory Research
5.2 By Application - Global Molecular Diagnostics Infectious Disease Testing Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2022
5.2.2 By Application - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2023-2028
5.2.3 By Application - Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics Infectious Disease Testing Market Size, 2021 & 2028
6.2 By Region - Global Molecular Diagnostics Infectious Disease Testing Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2022
6.2.2 By Region - Global Molecular Diagnostics Infectious Disease Testing Revenue, 2023-2028
6.2.3 By Region - Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2028
6.3.2 US Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.3.3 Canada Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.3.4 Mexico Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2028
6.4.2 Germany Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.4.3 France Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.4.4 U.K. Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.4.5 Italy Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.4.6 Russia Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.4.7 Nordic Countries Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.4.8 Benelux Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2028
6.5.2 China Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.5.3 Japan Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.5.4 South Korea Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.5.5 Southeast Asia Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.5.6 India Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2028
6.6.2 Brazil Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.6.3 Argentina Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnostics Infectious Disease Testing Revenue, 2017-2028
6.7.2 Turkey Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.7.3 Israel Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
6.7.5 UAE Molecular Diagnostics Infectious Disease Testing Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.1.4 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 BD
7.2.1 BD Corporate Summary
7.2.2 BD Business Overview
7.2.3 BD Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.2.4 BD Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.2.5 BD Key News
7.3 bioM?rieux
7.3.1 bioM?rieux Corporate Summary
7.3.2 bioM?rieux Business Overview
7.3.3 bioM?rieux Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.3.4 bioM?rieux Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.3.5 bioM?rieux Key News
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Corporate Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.4.4 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.4.5 Thermo Fisher Scientific Key News
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Corporate Summary
7.5.2 F. Hoffmann-La Roche Business Overview
7.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.5.4 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.5.5 F. Hoffmann-La Roche Key News
7.6 Siemens AG
7.6.1 Siemens AG Corporate Summary
7.6.2 Siemens AG Business Overview
7.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.6.4 Siemens AG Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.6.5 Siemens AG Key News
7.7 Veridex
7.7.1 Veridex Corporate Summary
7.7.2 Veridex Business Overview
7.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.7.4 Veridex Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.7.5 Veridex Key News
7.8 Luminex
7.8.1 Luminex Corporate Summary
7.8.2 Luminex Business Overview
7.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.8.4 Luminex Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.8.5 Luminex Key News
7.9 GenMark Diagnostics
7.9.1 GenMark Diagnostics Corporate Summary
7.9.2 GenMark Diagnostics Business Overview
7.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.9.4 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.9.5 GenMark Diagnostics Key News
7.10 Qiagen NV
7.10.1 Qiagen NV Corporate Summary
7.10.2 Qiagen NV Business Overview
7.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.10.4 Qiagen NV Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.10.5 Qiagen NV Key News
7.11 Genomix Biotech
7.11.1 Genomix Biotech Corporate Summary
7.11.2 Genomix Biotech Business Overview
7.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.11.4 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.11.5 Genomix Biotech Key News
7.12 BioTheranostics
7.12.1 BioTheranostics Corporate Summary
7.12.2 BioTheranostics Business Overview
7.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.12.4 BioTheranostics Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.12.5 BioTheranostics Key News
7.13 GenMark Diagnostics
7.13.1 GenMark Diagnostics Corporate Summary
7.13.2 GenMark Diagnostics Business Overview
7.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Major Product Offerings
7.13.4 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Revenue in Global Market (2017-2022)
7.13.5 GenMark Diagnostics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
